2026 NPPES data Physician Assistant NPI 1821312026 P.A.-C
Verify on CMS →

BINDU ALAKOT, P.A.-C

Physician Assistant in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 411 beneficiaries · Physician Assistant avg: 790
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.1335/100
▲ 7 pts above national avg 83.1 · [object Object]
What the federal data reveals: BINDU ALAKOT, P.A.-C is a Physician Assistant ([object Object]) practicing in DALLAS, Texas with a Medicare Part D prescribing footprint of 1K claims across 411 beneficiaries — 13% brand-name prescribing . Their CMS MIPS Final Score of 90.1335/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: BINDU ALAKOT, P.A.-C reported a CMS MIPS final score of 90.1335 out of 100, above the 83.1 national average, and filed 1,108 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

BINDU ALAKOT, P.A.-C at a glance

High performer (top quartile)

NPI registry status

Active

Issued 03/17/2010

NPI 1821312026

Primary specialty

Physician Assistant

High-volume

149,975 US NPIs in this specialty

Medicare Part D claims

1,108 40% vs specialty avg

2023 prescription claims

Specialty avg: 790

MIPS final score

90.1335/100 7.033500000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Physician Assistant compares to other specialties among Texas providers

Texas providers

Physician Assistant share within Texas

1. Physician Assistant42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Physician Assistant share within Texas

Medicare quality performance — MIPS

BINDU ALAKOT, P.A.-C's 2023 MIPS final score plotted against the Physician Assistant national average

High performer (top quartile)
MIPS Final Score
90.1335/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Physician Assistant) — 90.1335/100 vs national avg 83.1

0%100%National avg83%90.1%
MIPS final score (Physician Assistant) — 90.1335/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BINDU ALAKOT, P.A.-C is a Physician Assistant provider practicing in DALLAS, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: P.A.-C. NPI: 1821312026. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

BINDU ALAKOT, P.A.-C appears in the CMS NPPES registry as a Physician Assistant provider holding P.A.-C credentials at 8668 SKILLMAN ST, DALLAS, TX, 75243, with a listed phone of (214) 349-4909. NPI 1821312026 was issued on 03/17/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALAKOT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,108 prescription claims written by this provider, covering 411 Medicare beneficiaries and totaling roughly $70K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 3.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.1335/100 for the 2023 performance year (Quality 85.1149, Cost 63.4986), compared with the national average of 83.1.

Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8668 SKILLMAN ST
DALLAS, TX 75243

Provider Details

NPI 1821312026
Specialty Physician Assistant
Credentials P.A.-C
Gender Female
NPI Issued 03/17/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.1335
Final Score
Avg: 83.1
85.1149
Quality
63.4986
Cost
88
Promoting Interoperability

Reporting: Group practice

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to BINDU ALAKOT, P.A.-C. To verify BINDU ALAKOT, P.A.-C's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

BINDU ALAKOT, P.A.-C — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 1,108 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,108
Total Claims
$70K
Total Drug Cost
411
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,714
Total Day Supply
46,935
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$55K
Generic Drug Cost
$14K
Opioid Claims
35 (3.2% rate)
Antibiotic Claims
70

Patient Demographics

Average Patient Age
68.0 years
Avg HCC Risk Score
1.56
Gender Split
62% female / 38% male
Age Distribution
<65: 116, 65-74: 204, 75-84: 75, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amlodipine Besylate
98
Atorvastatin Calcium
71
Fluticasone Propionate
52
Lisinopril
38
Gabapentin
33
Ibuprofen
33
Metformin Hcl
32
Cyclobenzaprine Hcl
30
Hydrochlorothiazide
29
Tramadol Hcl
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Physician Assistant Overview

How BINDU ALAKOT, P.A.-C fits within the Physician Assistant landscape nationally.

149,975
Physician Assistant Providers in US
56
States with Physician Assistant
790
Avg Claims per Provider

BINDU ALAKOT, P.A.-C's 1,108 claims are above the specialty average of 790.

Nearby Physician Assistant Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ALAKOT.

Compare Physician Assistant nationally: see state-by-state distribution →

Frequently Asked Questions

What is BINDU ALAKOT, P.A.-C's specialty?
BINDU ALAKOT, P.A.-C specializes in Physician Assistant and practices in DALLAS, Texas. Credentials: P.A.-C.
How much does BINDU ALAKOT, P.A.-C prescribe under Medicare Part D?
In 2023, BINDU ALAKOT, P.A.-C wrote 1,108 Medicare Part D claims totaling $70K in drug costs for 411 beneficiaries.
What is BINDU ALAKOT, P.A.-C's Medicare quality score?
BINDU ALAKOT, P.A.-C has a CMS MIPS Final Score of 90.1335/100 (Quality: 85.1149, Cost: 63.4986). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BINDU ALAKOT, P.A.-C located?
BINDU ALAKOT, P.A.-C is located at 8668 SKILLMAN ST, DALLAS, TX, 75243. Phone: (214) 349-4909.
What is BINDU ALAKOT, P.A.-C's NPI number?
BINDU ALAKOT, P.A.-C's National Provider Identifier (NPI) is 1821312026, issued on 03/17/2010.
Does BINDU ALAKOT, P.A.-C prescribe more brand-name or generic drugs?
BINDU ALAKOT, P.A.-C's prescribing is 13% brand-name and 87% generic drugs by claim count, with $55K in brand drug costs.
Does BINDU ALAKOT, P.A.-C prescribe opioids?
Yes, BINDU ALAKOT, P.A.-C had 35 opioid claims in 2023 with an opioid prescribing rate of 3.2%.
How many Physician Assistant providers are there in the US?
There are 149,975 Physician Assistant providers across 56 states in the US. The average Physician Assistant provider writes 790 Medicare Part D claims per year.
What drugs does BINDU ALAKOT, P.A.-C prescribe most often?
Based on 2023 Medicare Part D data, BINDU ALAKOT, P.A.-C's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BINDU ALAKOT, P.A.-C accept Medicare?
BINDU ALAKOT, P.A.-C appears in CMS Medicare data with 1,108 Part D claims and 411 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BINDU ALAKOT, P.A.-C's credentials?
BINDU ALAKOT, P.A.-C's NPI is 1821312026 with credentials P.A.-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology